Study: Dopamine receptors at-risk for long-haul COVID-19 victims

SPOKANE, Wash. — One of the pressing questions that was asked during the pandemic was what the long-term effects of COVID-19 were on the body, if anything?

A new study is beginning to answer that question.

The study focuses on COVID-19 long-haulers – those people who battled symptoms for weeks after the virus was out of their system.

We’ve heard about the loss or smell or taste or lung issues. This is something different.

If you were one of the millions who was a long-hauler COVID-19 patient, the virus might have left a scar on more than just your immune system.

A new study from Columbia University, Cornell University and Sloan Kettering Cancer Center found evidence of the COVID-19 virus attacking dopamine receptors.

“Dopamine is a neurotransmitter that’s involved with our energy and our sense of pleasure,” Dr. Ken Isaacs said. “The absence of it results in sort of the opposite.”

This means feelings of anxiety or depression after a COVID-19 infection could be the direct result of COVD-19 attacking your nervous system.

Story continues